Ana Filipa Fonseca

Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany

Rolf Wachter, Ana Filipa Fonseca, Bogdan Balas et al. · European Journal of Heart Failure · 2019 · 66 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity

David M. Leistner, Andrés Laguna-Fernández, Arash Haghikia et al. · European Journal of Preventive Cardiology · 2024 · 51 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15

Caregivers of Patients with Heart Failure: Burden and the Determinants of Health-Related Quality of Life

Raquel Lahoz, Clare Proudfoot, Ana Filipa Fonseca et al. · Patient Preference and Adherence · 2021 · 48 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Recurrent Heart Failure Hospitalizations Increase the Risk of Cardiovascular and All-Cause Mortality in Patients with Heart Failure in Sweden: A Real-World Study

Krister Lindmark, Kurt Boman, Jan Stålhammar et al. · ESC Heart Failure · 2021 · 36 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank

Paul Welsh, A. Al Zabiby, Hannah Byrne et al. · Atherosclerosis · 2023 · 33 citations · Full text

Medicine, Cardiology, Genetics +17